chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One week after receiving the first vaccine in my right arm, I developed pain, swelling,  and redness around the injection site.  All symptoms resolved within 3 days.  I did not seek  medical treatment for this.  Prior to receiving the Econ?s vaccination, I discussed the previous symptoms with the staff.  After a bit of back and forth discussion I was informed that it was still advisable to proceed with the second vaccination. Approximately one hour after receiving the second vaccination in the left arm,  the arm began to swell and I developed a fever, chills, body and joint aches, headache, and loss of appetite. Within two days of receiving the injection, the arm was warm to the touch and had developed welts, redness, and tenderness. These symptoms have not resolved after 3 days.
Fever, 100.8, extreme chills, followed up by a headache behind my eyes, then sweats. Lasted about 12 hours and slowly going away now, still have the headache. Tylenol and advil were taken with out relief.
Twitching of nose upper part, eye and toe; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (Twitching of nose upper part, eye and toe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (Twitching of nose upper part, eye and toe). At the time of the report, MUSCLE TWITCHING (Twitching of nose upper part, eye and toe) outcome was unknown. Not Provided          Reporter did not allow further contact
after vaccine, pt sat 15 minutes and tried to get up and passed out. cashier went out to help check on her when she was going down. she came too. pt was talking and alert and remained sitting while paramedics were coming
she had her first dose of Shingrix administered in June 2019; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in June 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: she had her first dose of Shingrix administered in June 2019). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 06-NOV-2023 The consumer was the reporter.   Stated she had her 1st dose of Shingrix administered in June 2019. No further information was known. Till the time of reporting the patient did not received 2nd dose, which led to incomplete course of vaccination. The reporter did not consent to follow-up.
Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022; Patient received a vaccine past the 30 day storage on the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A .) for COVID-19 vaccination.     Concurrent medical conditions included Leiomyoma of uterus, unspecified and Drug allergy (CHLOROQUINE allergy). Concomitant products included PROPRANOLOL, IBUPROFEN, NORETHINDRONE [NORETHISTERONE] and LOSARTAN for an unknown indication.    On 06-Apr-2022 at 10:16 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022 at 10:16 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine past the 30 day storage on the refrigerator) and PRODUCT STORAGE ERROR (Date and time the vial was initially stored in the refrigerator on 25Feb2022 and date administered on 06 Apr 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 25-Feb-2022 the vial was initially stored in the refrigerator, its 30 day used by date was 25-Mar-2022. The vial did not undergo any temperature excursions. No Treatment information was reported
High fever 103-104 developed the night the aycebien was given. Fever lasted about 2 weeks. Also had a rash, which I did not see. He complained of feeling weak. Did not develop any neurologic symptoms.
Dizzyness/lightheaded; Tingling; Hot cold flashes; Extreme tiredness; This is a spontaneous report received from a non-contactable consumer. This 45-year-old female consumer (patient) reported for herself.   A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included levothyroxine sodium (SYNTHROID); esomeprazole sodium (NEXIUM); fexofenadine hydrochloride (ALLEGRA); probiotics (PROBIOTICS) and vitamin c [ascorbic acid] (VITAMIN C) all concomitant medications taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine prior to COVID-19 Vaccine. The patient did not test COVID-19 positive prior to vaccination. On an unspecified date, the patient reported that after receiving the first dose, within 5 mins experienced severe, dizzyness, lightheaded tingling, hot cold flashes all lasting 15-20 minutes, the next 24hrs extreme tiredness and arm soreness for few weeks after the 2nd shot. The patient had not been tested for COVID-19 since the vaccination. Treatment was not received for any of the events. Outcome of the events dizzyness, lightheaded tingling and hot cold flashes was reported as recovered. Outcome of the events extreme tiredness and arm soreness was reported as Unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This case was reported by a consumer via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 79-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received on an unknown date). On 17th December 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). In December 2018, less than a week after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb, injection site erythema, mass, injection site warmth and injection site itching. On 18th December 2018, the patient experienced feeling bad. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site erythema, mass, injection site warmth and injection site itching were unknown and the outcome of the feeling bad was recovered/resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb, feeling bad, injection site erythema, mass, injection site warmth and injection site itching to be related to SHINGRIX. Additional details were provided as follows: The next day after vaccination, the patient felt really bad and this had resolved. The patient had arm swelling from injection site down to her elbow, redness around injection site about the size of a softball, two knots in her arm each about 1 inch in size, the injection site was warm to the touch and felt itchy. The reporter gave consent to follow up. This case has been linked with case US2018231003, reported by the same reporter.
When giving pt shot pt pulled left arm away suddenly causing needle to pull out of skin and vaccine run down arm. Pt was given LESS than half of dose of 0.3ml. Pharmacy and Floor Lead notified - Clinic Manager advised to give another dose of 0.3ml. Pt taken into EMS Room and vaccine given without problems or difficulty. Pt and husband then escorted to observatiion for 15 min wait.
No adverse events occurred. Patient received a 3rd dose of COVID-19 per doctor's request. A prescription was written.
Approx 11 hours after receiving Pnemovax in lt deltoid, lt arm started swelling, was hot to touch, pain in muscle, and lt hand turned purple.
On 03/05/2001 the patient experienced a chicken pox outbreak, greater than 20 pox, mostly on the trunk and groin areas. The patient experienced nausea and vomiting. The patient had no fever. The reporter was not sure if the patient was exposed to a wild type virus. No additional information is expected.
Flutter in my heart beat; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 11:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included FLONASE, ZYRTEC, and Vitamin D (MANUFACTURER UNKNOWN). All since unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 26Mar2021 at 11:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021 at 20:00, 9 hours after being given the second vaccination, the patient experienced flutter in her heart beat which seemed to be taking place every 5-10 minutes. The events resulted in a visit to the doctors or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if any therapeutic measures were taken for the reported events. The clinical outcome of the event flutter in the patient's heart beat was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
I am unsure if I got the correct brand of each shot. Reactions: Friday at about 5 o'clock patient starting running a low grade fever. It never went over 100.9. Saturday the fever returned around 4 o'clock. Again low grade. Sunday the fever returned around 3. All three days he was more tired than usual and loss of appetite. Monday he woke up with small pinpoint red dots on his face, trunk, and back, legs and arms. His appetite returned. Today, Tue the 17th of October, the spots are still present. He is more tired than normal and clingy. Just as children who are sick.
Anytime I get stressed I develop hives from my chest down to my knee. The concentration is usually in the area but does affect other areas. My lips, my back, neck, and face. I went to urgent care, and they gave me a steroid shot and Hydroxyzine and Montelukast Sodium around February 12, 2023, and March 04, 2023. I have had flare ups off and on, but I went to urgent care. My doctor prescribed Famotidine and told me to take over the counter Claritin. The symptoms are very noticeable. They are bright red like mosquito bites. The most recent flare covered the entirety of my body excluding my neck. I have also had a lot of joint pain. I have arthritis. The pain in my hips and ankle are new. I was not prescribed any medication to treat these symptoms.
On the morning of 02/14/2021 I've noticed a swollen reddened, hardened  area to my left upper arm where injection was administered. The site is itchy and increasingly sore.  As the day has progressed the swelling has increased.
I am allergic to multi dose solution of injectable vaccines and medications. Covid vaccine is only available in multi dose. I took benedryl and albuterol inhaler before injection and symptoms were managed.
Shortness of breath x 10 min, pt discloses having anxiety in certain public places and have these type of 'attacks", V/S normal. Observed for another 15 min, pt recovered and  was released by doctor on duty.
allergic reaction to Gardasil- giant hives; This spontaneous report as received from a patient herself via Pfizer (manufacturer control # 2021330267) refers to a 18-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.     On an unknown date in May 2009, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis.         On an unknown date, when the patient was in high school, right before she was supposed to go to prom, she experienced an allergic reaction to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). No one knew or figured out what the active ingredient she was allergic to in the first place. The patient was rushed to the hospital at the time and had giant hives everywhere. The patient did not know if the reaction was from an active ingredient or what, as this happened to her when she was 18 years old and she did not have records of this event. Since she was in high school, her parents took care of it. She did not get the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  The outcome of the event was unknown. The reporter considered the event to be related to Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL).  Upon internal review, the event of giant hives was determined to be medically significant.
diffuse urticaria. no angioedema. no involvement mucosal surfaces. starting few hours after administration of vaccine. seen by urgent care 2 days later adn started on zyrtec and prednisone. urticaria symptoms persist on day 4 despite treatment
Mom reports that the child developed 103.5F temperature, bodyaches, chills, and a headache the evening of the same date he received the vacicne
RASH DEVELOPMENT IN ABDOMINAL AREA, THEN BOTH CALF, THEN LEGS AND ARMS, THEN GENERALIZED RASH WITH SEVERE ITCH
itchy mouth; Itchy swollen lips; red swollen face; whole body is itchy; This spontaneous case was reported by a consumer and describes the occurrence of ORAL PRURITUS (itchy mouth), LIP SWELLING (Itchy swollen lips), ERYTHEMA (red swollen face) and PRURITUS (whole body is itchy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057G20A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced ORAL PRURITUS (itchy mouth), LIP SWELLING (Itchy swollen lips), ERYTHEMA (red swollen face) and PRURITUS (whole body is itchy). At the time of the report, ORAL PRURITUS (itchy mouth), LIP SWELLING (Itchy swollen lips), ERYTHEMA (red swollen face) and PRURITUS (whole body is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Immediately after I received the shot I went and sat down and felt a cold from head to toe, I then started to feel nauseous. The nurse came to ask what was wrong and as I started to speak I went into an asthma attack. They walked me behind a screen and laid me on the gurney and I couldn't feel my legs and I felt a weird energy in my legs and body. They kept me over three hours. I finally went home and had to use my inhaler multiple times a day and I was still having issues with walking on my legs. That lasted six weeks and I followed up with my doctor via web visit and he said to not get the next series in the vaccine.
Extreme Fatigue/Malaise (24 hours). Full body aches (24 hours). Chills (5-6 hours).
This spontaneous report as received from a 67 year old female consumer with scoliosis and no drug reactions/allergies who on 04-JUL-2012, was vaccinated SQ with a dose of ZOSTAVAX (lot# 90736). Concomitant medication included "propanol", "mitroval", "synthestaton (cholesterol)" and inhalers. The consumer stated that she received ZOSTAVAX vaccine and 5 days later "on 09-JUL-2012", she got a case of shingles. The consumer did not receive any treatment. She did not seek medical attention. At the time of the report, the consumer outcome was unknown. The relatedness for case of shingles is unknown for ZOSTAVAX. No further information is available.
Date and time adverse event started: Sunday 3/21/21 patient took vaccine at 1:20pm and on sunday night patient started to feel very very cold with extreme body pain. Pain continued on Monday 3/22/21 with the addition of headache, swollen tonsils with pus in back of throat (white/yellow), gland under her armpit is swollen (left arm-injection arm), dry mouth and dry lips  Patient has contacted her PCP but they didn't want to see patient yet. PCP stated they don't want to prescribe the patient any meds due to MD not knowledgeable of vaccine and any contraindications. Patient has not taken any tylenol/ibuprofen after the vaccine
inadvertent administration of an expired dose of Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a male patient who received DTPa-IPV (Kinrix) (batch number 5R3KX, expiry date 26-MAY-2023) for prophylaxis.   On 15-JUN-2023, the patient received Kinrix. On 15-JUN-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: inadvertent administration of an expired dose of Kinrix). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 23-JUN-2023 The healthcare professional called to inform about the inadvertent administration of an expired dose of Kinrix which led to expired vaccine used. According to healthcare professional, the patient had no more than 10 years old The Vaccine Administration Facility is the same as Primary Reporter.  The reporter consented to follow up.
Pt recvd a series of 3 Engerix-B vax on 20DEC89, 31JAN90 & 7JUN90 subsequently tested for Hep B antibodies & found not to have converted;
warm to Touch; arm was itchy around injection site; rash around injection site; arm was really sore and knot pain; This spontaneous case was reported by a physician assistant and describes the occurrence of PAIN IN EXTREMITY (arm was really sore and knot pain), VACCINATION SITE WARMTH (warm to Touch), VACCINATION SITE PRURITUS (arm was itchy around injection site) and VACCINATION SITE RASH (rash around injection site) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was really sore and knot pain). On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (arm was itchy around injection site) and VACCINATION SITE RASH (rash around injection site). On an unknown date, the patient experienced VACCINATION SITE WARMTH (warm to Touch). On 14-Jan-2021, PAIN IN EXTREMITY (arm was really sore and knot pain) had resolved. On 20-Jan-2021, VACCINATION SITE PRURITUS (arm was itchy around injection site) had resolved. At the time of the report, VACCINATION SITE WARMTH (warm to Touch) and VACCINATION SITE RASH (rash around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain). At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
On 9/25 he awoke from sleep in the morning with severe left-sided chest pain.  On the night prior he had chills but no other symptoms of infection.  Chest pain felt similar to his episode of myocarditis 10 years ago.  He presented to hospital, troponin was elevated, echo showed wall motion abnormality, ECG was abnormal but nonspecific.  Symptoms improved.  Coronary angiogram showed no significant CAD.  He was diagnosed with myocarditis, and was discharged. Other Viral laboratory markers were negative   He returned with recurrent chest pain 1 day later, there were no new findings.  Echocardiogram showed improved LV wall motion wall motion and EF.  Cardiac MRI showed normal LVEF and no late gadolinium enhancement. Patient was diagnosed with Myocarditis felt to be 2/2 MonkeyPox Vaccine.
she clarified to her second Moderna shot she had severe pain in her breast; Got her period early; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (she clarified to her second Moderna shot she had severe pain in her breast), MENSTRUATION IRREGULAR (Got her period early) and PYREXIA (Fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced BREAST PAIN (she clarified to her second Moderna shot she had severe pain in her breast), MENSTRUATION IRREGULAR (Got her period early) and PYREXIA (Fever). At the time of the report, BREAST PAIN (she clarified to her second Moderna shot she had severe pain in her breast), MENSTRUATION IRREGULAR (Got her period early) and PYREXIA (Fever) outcome was unknown.            The concomitant history was not reported.   The treatment history was not provided.   This case was linked to MOD-2022-575213 (Patient Link).